pubmed-article:1457357 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:1457357 | lifeskim:mentions | umls-concept:C0008059 | lld:lifeskim |
pubmed-article:1457357 | lifeskim:mentions | umls-concept:C0019829 | lld:lifeskim |
pubmed-article:1457357 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
pubmed-article:1457357 | lifeskim:mentions | umls-concept:C0332325 | lld:lifeskim |
pubmed-article:1457357 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:1457357 | pubmed:dateCreated | 1993-1-14 | lld:pubmed |
pubmed-article:1457357 | pubmed:abstractText | During the period 1974-89, 169 children with Hodgkin's disease were treated in the Paediatric Oncology Units of the Royal Marsden and St Bartholomew's Hospitals. The overall actuarial survival for the whole group was 81% at 10 years. Thirty-five of the 169 children either did not achieve a complete remission or subsequently relapsed. The estimated actuarial survival from initial relapse or failure of primary treatment was 60% at 5 years and 45% at 10 years. Over half of the patients requiring salvage therapy had declared themselves within 2 years and only 3 relapses occurred more than 3 years from diagnosis. Very few patients remain disease free long term after failure of primary and initial salvage therapy. Patients relapsing within a year of diagnosis or not achieving a complete response to primary therapy and those with disseminated relapse had a poor response to salvage therapy. A significant subgroup of patients had prolonged survival despite multiple relapses. Neither initial histology nor stage affected survival from relapse although numbers in each subgroup were small. | lld:pubmed |
pubmed-article:1457357 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1457357 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1457357 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1457357 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1457357 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1457357 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1457357 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1457357 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1457357 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1457357 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1457357 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1457357 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1457357 | pubmed:language | eng | lld:pubmed |
pubmed-article:1457357 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1457357 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:1457357 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:1457357 | pubmed:month | Dec | lld:pubmed |
pubmed-article:1457357 | pubmed:issn | 0007-0920 | lld:pubmed |
pubmed-article:1457357 | pubmed:author | pubmed-author:BarretoFF | lld:pubmed |
pubmed-article:1457357 | pubmed:author | pubmed-author:McElwainT JTJ | lld:pubmed |
pubmed-article:1457357 | pubmed:author | pubmed-author:MalpasJ SJS | lld:pubmed |
pubmed-article:1457357 | pubmed:author | pubmed-author:PinkertonRR | lld:pubmed |
pubmed-article:1457357 | pubmed:author | pubmed-author:SandlandRR | lld:pubmed |
pubmed-article:1457357 | pubmed:author | pubmed-author:PlowmanP NPN | lld:pubmed |
pubmed-article:1457357 | pubmed:author | pubmed-author:MellerSS | lld:pubmed |
pubmed-article:1457357 | pubmed:author | pubmed-author:KingstonJ EJE | lld:pubmed |
pubmed-article:1457357 | pubmed:author | pubmed-author:JamesN DND | lld:pubmed |
pubmed-article:1457357 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:1457357 | pubmed:volume | 66 | lld:pubmed |
pubmed-article:1457357 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:1457357 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:1457357 | pubmed:pagination | 1155-8 | lld:pubmed |
pubmed-article:1457357 | pubmed:dateRevised | 2010-9-7 | lld:pubmed |
pubmed-article:1457357 | pubmed:meshHeading | pubmed-meshheading:1457357-... | lld:pubmed |
pubmed-article:1457357 | pubmed:meshHeading | pubmed-meshheading:1457357-... | lld:pubmed |
pubmed-article:1457357 | pubmed:meshHeading | pubmed-meshheading:1457357-... | lld:pubmed |
pubmed-article:1457357 | pubmed:meshHeading | pubmed-meshheading:1457357-... | lld:pubmed |
pubmed-article:1457357 | pubmed:meshHeading | pubmed-meshheading:1457357-... | lld:pubmed |
pubmed-article:1457357 | pubmed:meshHeading | pubmed-meshheading:1457357-... | lld:pubmed |
pubmed-article:1457357 | pubmed:meshHeading | pubmed-meshheading:1457357-... | lld:pubmed |
pubmed-article:1457357 | pubmed:meshHeading | pubmed-meshheading:1457357-... | lld:pubmed |
pubmed-article:1457357 | pubmed:meshHeading | pubmed-meshheading:1457357-... | lld:pubmed |
pubmed-article:1457357 | pubmed:meshHeading | pubmed-meshheading:1457357-... | lld:pubmed |
pubmed-article:1457357 | pubmed:meshHeading | pubmed-meshheading:1457357-... | lld:pubmed |
pubmed-article:1457357 | pubmed:meshHeading | pubmed-meshheading:1457357-... | lld:pubmed |
pubmed-article:1457357 | pubmed:meshHeading | pubmed-meshheading:1457357-... | lld:pubmed |
pubmed-article:1457357 | pubmed:year | 1992 | lld:pubmed |
pubmed-article:1457357 | pubmed:articleTitle | Outcome of children with resistant and relapsed Hodgkin's disease. | lld:pubmed |
pubmed-article:1457357 | pubmed:affiliation | Department of Paediatric Oncology, St Bartholomew's Hospital, West Smithfield, London, UK. | lld:pubmed |
pubmed-article:1457357 | pubmed:publicationType | Journal Article | lld:pubmed |